微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.99% | -5.08% | -67.75% | 32/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 9.27% | -11.46% | 18.54% | 33/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 7.82% | -4.87% | 45.08% | 40/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.39% | -10.61% | 71.11% | 32/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.15% | -9.74% | -69.91% | 26/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.47% | -9.35% | 27.37% | 29/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.22% | -12.46% | 36.32% | 36/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.03% | -9.6% | 72.78% | 28/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.49% | -9.11% | -69.78% | 27/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 11.55% | 8.96% | 23% | 33/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.39% | 5.62% | 40.78% | 34/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.67% | 26.81% | 73.7% | 29/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.84% | 17.79% | -63.77% | 19/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 10.6% | 18.04% | 19.24% | 40/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.89% | 1.95% | 69.01% | 43/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.26% | -5.4% | 61.35% | 51/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.26% | 22.56% | -63.7% | 38/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 8.98% | 7.93% | 2.98% | 63/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.72% | 12.37% | 56.83% | 42/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.56% | 9.23% | 109.02% | 44/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.66% | -14.74% | -68.03% | 37/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.32% | 4.26% | 7.22% | 65/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 7.76% | -7.95% | 52.46% | 47/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.09% | -1.17% | 63.14% | 46/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.12% | 3.65% | -60.9% | 35/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 7.98% | 1.01% | -5.34% | 66/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.43% | -73.62% | 63.69% | 37/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.15% | -1.53% | 71.1% | 38/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.01% | -13.93% | -61.9% | 29/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.9% | 21.54% | -75.27% | 66/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 31.95% | 313.86% | 510.9% | 2/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 5.23% | 11.51% | 49.56% | 39/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.5% | 5.11% | -46.2% | 17/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 6.5% | -18.75% | -15.8% | 73/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 7.72% | -19.25% | 64.61% | 36/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.69% | -25.65% | 40.97% | 41/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.33% | -17.09% | -58.41% | 24/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 8% | 5.26% | -16.32% | 57/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 9.56% | 32.96% | 51.55% | 29/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 6.31% | 41.66% | 57.19% | 27/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 4.01% | 38.38% | -47.2% | 18/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |